What is CUSIP 05070R104?

CUSIP 05070R104 is the security identifier used in SEC filing datasets for BOLD - AUDENTES THERAPEUTICS INC - COM.

Who owns BOLD - AUDENTES THERAPEUTICS INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

Security Snapshot

AUDENTES THERAPEUTICS INC - COM (BOLD) Institutional Ownership

CUSIP: 05070R104

13F Institutional Holders and Ownership History from Q3 2016 to Q1 2020

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period

Security type / class: Equity / COM
Symbol: BOLD on Nasdaq

13F Shares, Excluding Options vs Price

13F Value, Excluding Options

Total Investors

Key facts

BOLD - AUDENTES THERAPEUTICS INC - COM is tracked under CUSIP 05070R104.
Latest finished 13F holder period is not available.
Schedule 13D/13G significant owner rows are not currently available.

Change

Holder count moved from 185 to 0 between Q4 2019 and Q1 2020.
SEC-reported value moved from $2,574,456,027 to $0.

Research use

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

05070R104

Latest holder period

n/a

13F holders

13D/G owners

CIK / CUSIP context first

BOLD full holder history Boundless Bio, Inc. SEC filings Boundless Bio, Inc. company facts Boundless Bio, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 05070R104:

Q1 2020 (0 holders) Q4 2019 (185 holders) Q3 2019 (142 holders) Q2 2019 (145 holders) Q1 2019 (137 holders) Q4 2018 (125 holders) Q3 2018 (113 holders) Q2 2018 (121 holders) Q1 2018 (112 holders) Q4 2017 (86 holders)

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods

Latest

n/a

Rows shown

1-15 of 15

Period	13F Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2020 Q1	0	$0	-$2,559,723,450	$0	$0		0
2019 Q4	43,024,345	$2,574,456,027	+$256,265,768	$80,549,000	$10,083,000	$59.84	185
2019 Q3	44,600,296	$1,252,786,822	+$1,632,937	$1,472,000	$1,096,000	$28.09	142
2019 Q2	44,668,919	$1,691,004,753	+$93,116,243	$1,844,000	$10,154,000	$37.86	145
2019 Q1	43,738,394	$1,706,572,305	+$30,876,825	$807,000	$2,832,000	$39.02	137
2018 Q4	43,113,813	$919,169,824	+$134,248,878	$429,000	$1,017,000	$21.32	125
2018 Q3	36,129,389	$1,430,324,014	+$4,656,744	$1,951,000	$2,807,000	$39.59	113
2018 Q2	36,046,535	$1,377,317,197	+$59,316,112	$4,184,000	$1,750,000	$38.21	121
2018 Q1	34,677,880	$1,042,053,309	+$263,768,588	$2,374,000	$2,092,000	$30.05	112
2017 Q4	24,559,929	$767,585,500	+$32,219,505			$31.25	86
2017 Q3	23,564,935	$660,436,938	+$64,800,303			$28.01	79
2017 Q2	21,394,154	$409,288,640	+$106,420,530			$19.13	69
2017 Q1	15,960,466	$271,964,916	+$22,292,094			$17.04	57
2016 Q4	15,502,801	$282,793,160	+$1,573,670			$18.27	55
2016 Q3	15,421,847	$272,037,347	+$272,037,347			$17.81	49